Non-squamous cell carcinoma (SCC) of the larynx represents approximately 5% of
laryngeal malignancies. 1 These malignancies originate from minor salivary glands, bone …

The poorly differentiated neuroendocrine carcinomas (NECs) of the larynx are rare tumors
that comprise of a small cell-type (SCNEC) and a large cell-type (LCNEC). In order to …

Primary neuroendocrine carcinomas (NECs) of the larynx and head and neck are an
uncommon and heterogeneous group of neoplasms categorized by the 2017 WHO …

Laryngeal cancer (LC) remains a challenging disease to treat. The majority of LCs
diagnosed worldwide are squamous cell carcinomas (SCC), and current treatment …

The differential diagnosis of neuroendocrine neoplasms of the larynx is broad and includes
lesions of epithelial, mesenchymal, and neuroectodermal origin. These lesions have …

Primary ovarian carcinoid tumors are rare neoplasms that constitute less than 0.1% of all
ovarian carcinomas. However, carcinoid tumors metastatic to ovaries are more common …

Neuroendocrine neoplasms (NENs) of the head and neck are a rare group of
heterogeneous epithelial neoplastic proliferations arising in virtually all of the different …

Background High‐grade neuroendocrine carcinoma of the larynx (HG‐NECL) is rare and
aggressive with limited data regarding response to systemic therapy. We evaluated …

Background The purpose of this retrospective analysis was to build and validate nomograms
to predict the cancer-specific survival (CSS) and overall survival (OS) of head and neck …

Highlights This Clinical Practice Guideline provides key recommendations for managing
rare endocrine tumours. Neuroendocrine neoplasms of different origins, parathyroid …